Literature DB >> 21911460

Cathepsin G and neutrophil elastase play critical and nonredundant roles in lung-protective immunity against Streptococcus pneumoniae in mice.

Ines Hahn1, Anna Klaus, Ann-Kathrin Janze, Kathrin Steinwede, Nadine Ding, Jennifer Bohling, Christina Brumshagen, Hélène Serrano, Francis Gauthier, James C Paton, Tobias Welte, Ulrich A Maus.   

Abstract

Neutrophil serine proteases cathepsin G (CG), neutrophil elastase (NE), and proteinase 3 (PR3) have recently been shown to contribute to killing of Streptococcus pneumoniae in vitro. However, their relevance in lung-protective immunity against different serotypes of S. pneumoniae in vivo has not been determined so far. Here, we examined the effect of CG and CG/NE deficiency on the lung host defense against S. pneumoniae in mice. Despite similar neutrophil recruitment, both CG knockout (KO) mice and CG/NE double-KO mice infected with focal pneumonia-inducing serotype 19 S. pneumoniae demonstrated a severely impaired bacterial clearance, which was accompanied by lack of CG and NE but not PR3 proteolytic activity in recruited neutrophils, as determined using fluorescence resonance energy transfer (FRET) substrates. Moreover, both CG and CG/NE KO mice but not wild-type mice responded with increased lung permeability to infection with S. pneumoniae, resulting in severe respiratory distress and progressive mortality. Both neutrophil depletion and ablation of hematopoietic CG/NE in bone marrow chimeras abolished intra-alveolar CG and NE immunoreactivity and led to bacterial outgrowth in the lungs of mice, thereby identifying recruited neutrophils as the primary cellular source of intra-alveolar CG and NE. This is the first study showing a contribution of neutrophil-derived neutral serine proteases CG and NE to lung-protective immunity against focal pneumonia-inducing serotype 19 S. pneumoniae in mice. These data may be important for the development of novel intervention strategies to improve lung-protective immune mechanisms in critically ill patients suffering from severe pneumococcal pneumonia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21911460      PMCID: PMC3232647          DOI: 10.1128/IAI.05593-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G.

Authors:  J Tkalcevic; M Novelli; M Phylactides; J P Iredale; A W Segal; J Roes
Journal:  Immunity       Date:  2000-02       Impact factor: 31.745

2.  Killing activity of neutrophils is mediated through activation of proteases by K+ flux.

Authors:  Emer P Reeves; Hui Lu; Hugues Lortat Jacobs; Carlo G M Messina; Steve Bolsover; Giorgio Gabella; Eric O Potma; Alice Warley; Jürgen Roes; Anthony W Segal
Journal:  Nature       Date:  2002-03-21       Impact factor: 49.962

3.  Importance of CXC chemokine receptor 2 in alveolar neutrophil and exudate macrophage recruitment in response to pneumococcal lung infection.

Authors:  Wiebke Herbold; Regina Maus; Ines Hahn; Nadine Ding; Mrigank Srivastava; John W Christman; Matthias Mack; Jörg Reutershan; David E Briles; James C Paton; Christine Winter; Tobias Welte; Ulrich A Maus
Journal:  Infect Immun       Date:  2010-04-05       Impact factor: 3.441

4.  Keratinocyte growth factor augments pulmonary innate immunity through epithelium-driven, GM-CSF-dependent paracrine activation of alveolar macrophages.

Authors:  Huixing Wu; Takuji Suzuki; Brenna Carey; Bruce C Trapnell; Francis X McCormack
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

5.  Dendritic cell depletion and repopulation in the lung after irradiation and bone marrow transplantation in mice.

Authors:  Ines Hahn; Anna Klaus; Regina Maus; John W Christman; Tobias Welte; Ulrich A Maus
Journal:  Am J Respir Cell Mol Biol       Date:  2010-12-22       Impact factor: 6.914

6.  Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase.

Authors:  A Belaaouaj; K S Kim; S D Shapiro
Journal:  Science       Date:  2000-08-18       Impact factor: 47.728

Review 7.  Alpha-1 antitrypsin deficiency: whom to test, whom to treat?

Authors:  Robert A Sandhaus
Journal:  Semin Respir Crit Care Med       Date:  2010-05-21       Impact factor: 3.119

Review 8.  Of mice and men: innate immunity in pneumococcal pneumonia.

Authors:  Esther Calbo; Javier Garau
Journal:  Int J Antimicrob Agents       Date:  2009-12-14       Impact factor: 5.283

9.  Structural characterization of mouse neutrophil serine proteases and identification of their substrate specificities: relevance to mouse models of human inflammatory diseases.

Authors:  Timofey Kalupov; Michèle Brillard-Bourdet; Sébastien Dadé; Hélène Serrano; Julien Wartelle; Nicolas Guyot; Luiz Juliano; Thierry Moreau; Azzaq Belaaouaj; Francis Gauthier
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

10.  Human neutrophils kill Streptococcus pneumoniae via serine proteases.

Authors:  Alistair J Standish; Jeffrey N Weiser
Journal:  J Immunol       Date:  2009-07-20       Impact factor: 5.422

View more
  54 in total

1.  Molecular network, pathway, and functional analysis of time-dependent gene changes related to cathepsin G exposure in neonatal rat cardiomyocytes.

Authors:  Sanket Kumar Shukla; Kunal Sikder; Amrita Sarkar; Sankar Addya; Khadija Rafiq
Journal:  Gene       Date:  2018-05-31       Impact factor: 3.688

Review 2.  Mast cell proteases as pharmacological targets.

Authors:  George H Caughey
Journal:  Eur J Pharmacol       Date:  2015-05-07       Impact factor: 4.432

3.  Macrophage-inducible C-type lectin Mincle-expressing dendritic cells contribute to control of splenic Mycobacterium bovis BCG infection in mice.

Authors:  Friederike Behler; Regina Maus; Jennifer Bohling; Sarah Knippenberg; Gabriele Kirchhof; Masahiro Nagata; Danny Jonigk; Nicole Izykowski; Lavinia Mägel; Tobias Welte; Sho Yamasaki; Ulrich A Maus
Journal:  Infect Immun       Date:  2014-10-20       Impact factor: 3.441

4.  C-rac-king the Code of Smoke-induced Pneumonia Susceptibility.

Authors:  Lee J Quinton
Journal:  Am J Respir Crit Care Med       Date:  2018-11-15       Impact factor: 21.405

5.  Extracellular adenosine enhances the ability of PMNs to kill Streptococcus pneumoniae by inhibiting IL-10 production.

Authors:  Nalat Siwapornchai; James N Lee; Essi Y I Tchalla; Manmeet Bhalla; Jun Hui Yeoh; Sara E Roggensack; John M Leong; Elsa N Bou Ghanem
Journal:  J Leukoc Biol       Date:  2020-02-04       Impact factor: 4.962

6.  Lactobacillus priming of the respiratory tract: Heterologous immunity and protection against lethal pneumovirus infection.

Authors:  Katia E Garcia-Crespo; Calvin C Chan; Stanislaw J Gabryszewski; Caroline M Percopo; Peter Rigaux; Kimberly D Dyer; Joseph B Domachowske; Helene F Rosenberg
Journal:  Antiviral Res       Date:  2012-12-26       Impact factor: 5.970

7.  DNA structures decorated with cathepsin G/secretory leukocyte proteinase inhibitor stimulate IFNI production by plasmacytoid dendritic cells.

Authors:  Joanna Skrzeczynska-Moncznik; Agnieszka Wlodarczyk; Magdalena Banas; Mateusz Kwitniewski; Katarzyna Zabieglo; Monika Kapinska-Mrowiecka; Adam Dubin; Joanna Cichy
Journal:  Am J Clin Exp Immunol       Date:  2013-06-15

8.  Testing Anti-Pneumococcal Antibody Function Using Bacteria and Primary Neutrophils.

Authors:  Manmeet Bhalla; Shaunna R Simmons; Essi Y I Tchalla; Elsa N Bou Ghanem
Journal:  Methods Mol Biol       Date:  2021

9.  FMS-like tyrosine kinase 3 ligand treatment of mice aggravates acute lung injury in response to Streptococcus pneumoniae: role of pneumolysin.

Authors:  Christina Brumshagen; Regina Maus; Andrea Bischof; Bianca Ueberberg; Jennifer Bohling; John J Osterholzer; Abiodun D Ogunniyi; James C Paton; Tobias Welte; Ulrich A Maus
Journal:  Infect Immun       Date:  2012-09-24       Impact factor: 3.441

Review 10.  Integrative Physiology of Pneumonia.

Authors:  Lee J Quinton; Allan J Walkey; Joseph P Mizgerd
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.